Phase I: At-Home Support for Rural Women Using Group Video Calling
At-Home Support for Rural Women Using Group Video Calling
3 other identifiers
interventional
34
1 country
2
Brief Summary
This randomized phase I trial studies at-home group video calling sessions in quality of life in rural patients with breast cancer. At-home group video calling support sessions may improve the well-being and quality of life of women who have breast cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1 depression
Started Oct 2012
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2012
CompletedFirst Posted
Study publicly available on registry
August 27, 2012
CompletedStudy Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedOctober 17, 2014
October 1, 2014
1.2 years
August 20, 2012
October 15, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility of the study protocol as determined primarily through qualitative analysis of the group sessions and the interview data
The major criterion for determining feasibility is to determine whether we can recruit rural women with breast cancer more rapidly using predominantly on-line procedures in this study than in our previous study that predominantly used face-to-face procedures. The qualitative data for determining the feasibility will be collected during the at-home group video calling sessions and from women's interviews conducted at the end of the study. Will be assessed using mixed methods.
At 1 week post-intervention
Acceptability of the study protocol as determined primarily through qualitative analysis of the group sessions and the interview data
The qualitative data for determining the acceptability will be collected during the at-home group video calling sessions and from women's interviews conducted at the end of the study. Will be assessed using mixed methods.
At 1 week post-intervention
Secondary Outcomes (3)
Changes in quality of life (posttraumatic stress, depression symptoms, perceived stress, and positive states of mind)
From baseline to 1 week post-intervention
Changes in satisfaction with social support
From baseline to 1 week post-intervention
Changes in self-efficacy for coping with cancer
From baseline to 1 week post-intervention
Study Arms (2)
Arm I (experimental arm)
EXPERIMENTALParticipants complete at-home group video calling sessions for 1 1/2 hours once weekly for 8 weeks.
Arm II (control arm)
ACTIVE COMPARATORParticipants receive an educational workbook journal.
Interventions
Complete at-home group video calling support sessions
Receive an educational workbook journal
Eligibility Criteria
You may qualify if:
- To be eligible for this study, the participant must have been diagnosed with breast cancer within the previous 5 years prior to study entry; individuals who have been diagnosed with any stage of breast cancer are eligible
- There are no limitations regarding allowable type and amount of prior therapy
- There are no race/ethnic restrictions
- There are no life expectancy restrictions
- Neither Eastern Cooperative Oncology Group (ECOG) nor Karnofsky performance status will be employed
- There are no requirements for organ and marrow function
- Ability to understand and the willingness to sign a written informed consent document; this will be assessed in the telephone screen conducted by Lisa Frankel as she will review each section of the consent form with the participant and ask if she has any questions about it; this telephone screen will have been approved by the Stanford University Institutional Review Board (IRB), and Lisa Frankel will conduct the interviews in a private location to ensure confidentiality
- Eligibility for this study requires that a woman be a resident of one of 27 rural counties in California (Alpine, Amador, Butte, Calaveras, Colusa, Del Norte, El Dorado, Glenn, Imperial, Inyo, Lake, Lassen, Madera, Mariposa, Modoc, Mono, Nevada, Placer, Plumas, Shasta, Sierra, Siskiyou, Sutter, Tehama, Trinity, Tuolumne, or Yuba, except we will not include women living within the following cities: Chico, Madera, Redding, Rocklin, Roseville or Yuba City, due to this study's more rural focus)
- Eligibility for this study requires that a woman has sufficient hearing to be able to engage in conversation over the phone
- Eligibility for this study requires that a woman has a private place available where she can access the internet
- Eligibility for this study requires that a woman is potentially available to meet at the day of the week and time of the day that the group intervention is scheduled â in the event that she is randomly assigned to receive the at-home group calling intervention
- Eligibility for this study requires that women have broadband or digital subscriber line (DSL) internet access
- Eligibility for this study requires that women have a computer with a webcam and either a microphone or a phone available to call into the video conference
You may not qualify if:
- There are no therapy restrictions
- There are no restrictions regarding use of other investigational agents
- Requirements regarding history of allergic reactions attributed to compounds of similar chemical or biologic composition to investigational agent or device are not applicable to this study
- Pregnancy or nursing patients will not be excluded from the study
- Patients who are cancer survivors or those who are human immunodeficiency virus (HIV)-positive will not be excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- California Breast Cancer Research Programcollaborator
Study Sites (2)
Sierra Streams Institute
Nevada City, California, 95959, United States
Stanford University Cancer Institute
Stanford, California, 94305, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cheryl Koopman
Stanford University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor (Research) of Psychiatry and Behavioral Sciences
Study Record Dates
First Submitted
August 20, 2012
First Posted
August 27, 2012
Study Start
October 1, 2012
Primary Completion
December 1, 2013
Study Completion
June 1, 2014
Last Updated
October 17, 2014
Record last verified: 2014-10